Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury.

Cusimano M, Brambilla E, Capotondo A, De Feo D, Tomasso A, Comi G, D'Adamo P, Muzio L, Martino G.

J Neuroinflammation. 2018 Feb 23;15(1):58. doi: 10.1186/s12974-018-1085-9.

2.

Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis.

Rossi C, Cusimano M, Zambito M, Finardi A, Capotondo A, Garcia-Manteiga JM, Comi G, Furlan R, Martino G, Muzio L.

Cell Death Dis. 2018 Feb 14;9(2):250. doi: 10.1038/s41419-018-0288-4.

3.

Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells.

Capotondo A, Milazzo R, Garcia-Manteiga JM, Cavalca E, Montepeloso A, Garrison BS, Peviani M, Rossi DJ, Biffi A.

Sci Adv. 2017 Dec 6;3(12):e1701211. doi: 10.1126/sciadv.1701211. eCollection 2017 Dec.

4.

Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.

Domi T, Porrello E, Velardo D, Capotondo A, Biffi A, Tonlorenzi R, Amadio S, Ambrosi A, Miyagoe-Suzuki Y, Takeda S, Ruegg MA, Previtali SC.

Skelet Muscle. 2015 Sep 3;5:30. doi: 10.1186/s13395-015-0055-5. eCollection 2015.

5.

Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation.

Capotondo A, Milazzo R, Politi LS, Quattrini A, Palini A, Plati T, Merella S, Nonis A, di Serio C, Montini E, Naldini L, Biffi A.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15018-23. doi: 10.1073/pnas.1205858109. Epub 2012 Aug 23.

6.

Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection.

Biffi A, Bartolomae CC, Cesana D, Cartier N, Aubourg P, Ranzani M, Cesani M, Benedicenti F, Plati T, Rubagotti E, Merella S, Capotondo A, Sgualdino J, Zanetti G, von Kalle C, Schmidt M, Naldini L, Montini E.

Blood. 2011 May 19;117(20):5332-9. doi: 10.1182/blood-2010-09-306761. Epub 2011 Mar 14.

7.

Development and maturation of invariant NKT cells in the presence of lysosomal engulfment.

Plati T, Visigalli I, Capotondo A, Buono M, Naldini L, Cosma MP, Biffi A.

Eur J Immunol. 2009 Oct;39(10):2748-54. doi: 10.1002/eji.200939639.

8.

Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy.

Cesani M, Capotondo A, Plati T, Sergi LS, Fumagalli F, Roncarolo MG, Naldini L, Comi G, Sessa M, Biffi A.

Hum Mutat. 2009 Oct;30(10):E936-45. doi: 10.1002/humu.21093.

PMID:
19606494
9.

Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy.

Capotondo A, Cesani M, Pepe S, Fasano S, Gregori S, Tononi L, Venneri MA, Brambilla R, Quattrini A, Ballabio A, Cosma MP, Naldini L, Biffi A.

Hum Gene Ther. 2007 Sep;18(9):821-36.

PMID:
17845130
10.

Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

Biffi A, Capotondo A, Fasano S, del Carro U, Marchesini S, Azuma H, Malaguti MC, Amadio S, Brambilla R, Grompe M, Bordignon C, Quattrini A, Naldini L.

J Clin Invest. 2006 Nov;116(11):3070-82.

Supplemental Content

Loading ...
Support Center